Search results
Results from the WOW.Com Content Network
Risk factors for tumor lysis syndrome depend on several different characteristics of the patient, the type of cancer, and the type of chemotherapy used. [14] Tumor characteristics: Tumors with a high cell turnover rate, rapid growth rate, and high tumor bulk tend to be more associated with the development of tumor lysis syndrome.
Zoledronic acid is used to prevent bone fractures in patients with cancers such as multiple myeloma and prostate cancer, as well as for treating osteoporosis. [10] It can also be used to treat hypercalcaemia of malignancy and can be helpful for treating pain from bone metastases. [11] It can be given at home rather than in hospital.
Raloxifene is used for the treatment and prevention of osteoporosis in postmenopausal women. [11] It is used at a dosage of 60 mg/day for both the prevention and treatment of osteoporosis. [12] In the case of either osteoporosis prevention or treatment, supplemental calcium and vitamin D should be added to the diet if daily intake is inadequate ...
The 7 best electrolyte drinks . Bonci stresses that you might have to try a few electrolyte products before you find your personal favorite, “One size does not fit all. Look at price, consider ...
Alendronic acid, sold under the brand name Fosamax among others, is a bisphosphonate medication used to treat osteoporosis and Paget's disease of bone. [4] It is taken by mouth. [ 4 ] Use is often recommended together with vitamin D , calcium supplementation , and lifestyle changes.
Classic Beef Bone Broth. Bone broth is packed with electrolytes, including calcium, magnesium, and phosphorus. Beef, chicken, and turkey broth all provide electrolytes and protein, but this beef ...
Electrochemotherapy (ECT [1]) is a type of chemotherapy that allows delivery of non-permeant drugs to the cell interior. It is based on the local application of short and intense electric pulses that transiently permeabilize the cell membrane, thus allowing transport of molecules otherwise not permitted by the membrane.
The Panova-3 trial enrolled 571 newly diagnosed pancreatic cancer patients with advanced-stage disease and randomized them to receive standard chemotherapy plus tumor-treating fields or just chemo ...